SCOTT ROSMAN: Open Payments
NPI 1568750651 · BINGHAMTON, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,077 in 101 payments from 18 companies in 2025. Trend: 2023 $4,925 · 2024 $3,131 · 2025 $2,077
Food & beverage: $2,077
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 31 | $552 |
| ViiV Healthcare Company | 11 | $324 |
| Gilead Sciences, Inc. | 11 | $194 |
| GlaxoSmithKline, LLC. | 12 | $155 |
| Astellas Pharma US Inc | 1 | $135 |
| Exact Sciences Corporation | 6 | $134 |
| AstraZeneca Pharmaceuticals LP | 7 | $120 |
| Merck Sharp & Dohme LLC | 5 | $102 |
| Novo Nordisk Inc | 3 | $75 |
| Amgen Inc. | 3 | $53 |
Products named: VRAYLAR, DOVATO, Cresemba, PIFELTRO, Cologuard Collection Kit, TRELEGY ELLIPTA, BREZTRI, AREXVY.
Industry payments across NY — which companies pay providers there.
